Agios Pharmaceuticals (AGIO) Amortizatization of Intangibles (2016 - 2026)
Agios Pharmaceuticals (AGIO) has disclosed Amortizatization of Intangibles for 15 consecutive years, with $1.1 million as the latest value for Q1 2026.
- For Q1 2026, Amortizatization of Intangibles fell 15.13% year-over-year to $1.1 million; the TTM value through Mar 2026 reached $7.0 million, down 47.46%, while the annual FY2025 figure was $7.2 million, 50.33% down from the prior year.
- Amortizatization of Intangibles hit $1.1 million in Q1 2026 for Agios Pharmaceuticals, up from -$2.0 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $8.8 million in Q3 2022 and bottomed at -$3.8 million in Q2 2022.
- Average Amortizatization of Intangibles over 5 years is $2.6 million, with a median of $2.6 million recorded in 2022.
- Year-over-year, Amortizatization of Intangibles soared 177.58% in 2023 and then crashed 134.37% in 2025.
- Agios Pharmaceuticals' Amortizatization of Intangibles stood at $2.6 million in 2022, then grew by 7.41% to $2.8 million in 2023, then surged by 114.97% to $5.9 million in 2024, then tumbled by 134.37% to -$2.0 million in 2025, then skyrocketed by 156.24% to $1.1 million in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $1.1 million, -$2.0 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.